What We're Reading: Page
Industry reads hand-picked by our editors
Mar 31, 2020
-
Slate
Didier Raoult: The Trumpian French doctor behind the chloroquine hype
-
STAT
A sickle cell doctor tracks dollars, disparities, and drug development
-
Los Angeles Times
Social distancing is slowing the coronavirus in Seattle. But it's not enough, study says
-
The New York Times
Covid-19 Has Closed Stores, but Snake Oil Is Still for Sale
Mar 30, 2020
Mar 27, 2020
-
The New York Times
The Unseen Survivors of Thalidomide Want to Be Heard
-
Axios
Top Trump administration health officials surprised by coronavirus drug's new status
-
The New Yorker
How Does the Coronavirus Behave Inside a Patient?
-
ProPublica
Republican Billionaire’s Group Pushes Unproven COVID-19 Treatment Trump Promoted
Mar 26, 2020
Mar 25, 2020
-
The Washington Post
The coronavirus isn't mutating quickly, suggesting a vaccine would offer lasting protection
-
Reuters
U.S. companies, labs rush to produce blood test for coronavirus immunity
-
STAT
India bans exports of drug touted by Trump as potential Covid-19 treatment
-
Regulatory Focus
Convalescent Plasma: FDA Facilitating Emergency Access
Mar 24, 2020
-
Bloomberg
China to Lift Lockdown Over Virus Epicenter Wuhan on April 8
-
The Wall Street Journal
Johnson & Johnson CFO Warns Coronavirus Uncertainty to Make Guidance '100% Precisely Wrong'
-
The New York TImes
Lost Sense of Smell May Be Peculiar Clue to Coronavirus Infection
-
AgencyIQ
As public health infrastructure battles COVID, the FDA transforms
Mar 23, 2020
-
Science
'I’m going to keep pushing.' Anthony Fauci tries to make the White House listen to facts of the pandemic
-
The New Yorker
In Boston, Doctors Wait for the Deluge of Coronavirus Patients
-
STAT
Covid-19 is reshaping the world of bioscience publishing
-
C&EN
Why Japan’s chemical firms still make drugs
Previous
